EARLE M. CHAPMAN
The description by Gordon1, 2 in 1932 of a biological test for Hodgkin's disease aroused widespread interest. Van Rooyen3 in Scotland made a trial of the test and later, in a paper published in this country, van Rooyen and Olgivie4 expressed the opinion that it had proved itself to be of definite clinical value. Our own evaluation of this test as a diagnostic aid in the differentiation of the Hodgkin's type of lymphoblastoma is presented here after three years of experience in which material from 16 cases of Hodgkin's disease and 30 cases of other types of lymphadenopathy has been
CHAPMAN EM. STUDIES IN HODGKIN'S DISEASE: III. CLINICAL APPLICATION OF THE GORDON TEST (A SYNDROME OF ATAXIA, SPASM AND PARALYSIS INDUCED IN RABBITS BY THE INTRACEREBRAL INJECTION OF EMULSIFIED HODGKIN'S TISSUE)1. Ann Intern Med. ;10:742–747. doi: 10.7326/0003-4819-10-6-742
Download citation file:
Published: Ann Intern Med. 1936;10(6):742-747.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use